Compare drug alternatives
Ubrelvy® Alternatives
Ubrelvy®
(ubrogepant)
Ubrelvy
-
Migraine
- Emgality®
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Qulipta®
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines.
Ubrelvy is FDA approved for the following indications: Migraine.
Vyepti®
(eptinezumab-jjmr)
Vyepti
-
Migraine
- Emgality®
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Qulipta®
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat.
Vyepti is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Oral
Intravenous infusion (must be diluted)
Dosing
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
100 mg every 3 months or 300 mg (for some patients)
Latin Shorthand
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.
100 mg q3mo
Financial Assistance
Copay
$0
$0
Annual Cap
Maximum savings of $50 per pill for up to 13 prescription fills.
$200 per infusion for administration costs
Assistance Expiration
13 prescription fills
Calendar year
Generics
No lower-cost generic available
No lower-cost generic available